The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

BACKGROUND: The proto-oncogene Src is an important non-receptor protein tyrosine kinase involved in signaling pathways that control cell adhesion, growth, migration and differentiation. It negatively regulates osteoblast activity, and, as such, its inhibition is a potential means to prevent bone los...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Id Boufker, Hichame, Lagneaux, Laurence, Najar, Mehdi, Piccart, Martine, Ghanem, Ghanem, Body, Jean-Jacques, Journé, Fabrice
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2010
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3087319/
https://ncbi.nlm.nih.gov/pubmed/20565769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-298
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak